Hims & Hers Health Return On Tangible Equity 2020-2025 | HIMS

Hims & Hers Health return on tangible equity for the quarter ending March 31, 2025 was 53.51.

  • Hims & Hers Health average return on tangible equity for 2024 was 24.21, a 206.84% increase from 2023.
  • Hims & Hers Health average return on tangible equity for 2023 was -22.66, a 41.84% decline from 2022.
  • Hims & Hers Health average return on tangible equity for 2022 was -38.96, a 51.26% decline from 2021.

Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.

Hims & Hers Health Return On Tangible Equity 2020-2025 | HIMS

  • Hims & Hers Health average return on tangible equity for 2024 was 24.21, a 206.84% increase from 2023.
  • Hims & Hers Health average return on tangible equity for 2023 was -22.66, a 41.84% decline from 2022.
  • Hims & Hers Health average return on tangible equity for 2022 was -38.96, a 51.26% decline from 2021.

Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Related Stocks
Company NameMarket
Cap
Veeva Systems (VEEV)$35.1B
Tempus AI (TEM)$7B
Inspire Medical Systems (INSP)$4.5B
IRhythm Technologies (IRTC)$3.2B
Privia Health (PRVA)$2.9B
Schrodinger (SDGR)$1.9B
Clover Health Investments (CLOV)$1.8B
Enovis (ENOV)$1.8B
Omnicell (OMCL)$1.4B
Phreesia (PHR)$1.4B
Azenta (AZTA)$1.2B
10x Genomics (TXG)$918M
Butterfly Network (BFLY)$568M
Fulgent Genetics (FLGT)$551M
Talkspace (TALK)$450M
Veradigm (MDRX)$449M
Standard BioTools (LAB)$440M
TruBridge (TBRG)$363M
Claritev (CTEV)$325M
Health Catalyst (HCAT)$270M
Nyxoah SA (NYXH)$206M
SOPHiA GENETICS SA (SOPH)$189M
Pulmonx (LUNG)$182M
American Well (AMWL)$109M
EUDA Health Holdings (EUDA)$100M
Retrieve Medical Holdings (RMHI)$82M
MDxHealth SA (MDXH)$76M
P3 Health Partners (PIII)$66M
111 (YI)$64M
CareCloud (CCLD)$60M